Correction to: Incident autoimmune diseases in association with SARS-CoV-2 infection: A matched cohort study

Research output: Contribution to specialist publicationCorrections (errata and retractions)peer-review

Contributors

  • Falko Tesch - , Center for Evidence-Based Healthcare (Author)
  • Franz Ehm - , Center for Evidence-Based Healthcare (Author)
  • Annika Vivirito - , Charité – Universitätsmedizin Berlin (Author)
  • Danny Wende - , BARMER Institut für Gesundheitssystemforschung (bifg) (Author)
  • Manuel Batram - , Vandage GmbH (Author)
  • Friedrich Loser - , Techniker Krankenkasse (Author)
  • Simone Menzer - , IKK classic (Author)
  • Josephine Jacob - , Charité – Universitätsmedizin Berlin (Author)
  • Martin Roessler - , Center for Evidence-Based Healthcare (Author)
  • Martin Seifert - , Center for Evidence-Based Healthcare (Author)
  • Barbara Kind - , Center for Evidence-Based Healthcare (Author)
  • Christina König - , Techniker Krankenkasse (Author)
  • Claudia Schulte - , BARMER Institut für Gesundheitssystemforschung (bifg) (Author)
  • Tilo Buschmann - , AOK PLUS (Author)
  • Dagmar Hertle - , BARMER Institut für Gesundheitssystemforschung (bifg) (Author)
  • Pedro Ballesteros - , BARMER Institut für Gesundheitssystemforschung (bifg) (Author)
  • Stefan Baßler - , AOK PLUS (Author)
  • Barbara Bertele - , Techniker Krankenkasse (Author)
  • Thomas Bitterer - , IKK classic (Author)
  • Cordula Riederer - , DAK-Gesundheit (Author)
  • Franziska Sobik - , DAK-Gesundheit (Author)
  • Lukas Reitzle - , Robert Koch-Institut (Author)
  • Christa Scheidt-Nave - , Robert Koch-Institut (Author)
  • Jochen Schmitt - , Center for Evidence-Based Healthcare (Author)

Abstract

The Figs. 1 and 2 images of the original published version of the above article were interchanged. Now the Figures have been corrected, and the legends remain unchanged as follows: (Figure presented.) (Figure presented.) Flowchart for the selection of the COVID-19 and control groups Forest plot comparing incident rate ratios for any first-onset autoimmune disease 3 to 15 months after SARS-CoV-2 infection by subgroup.

Details

Original languageEnglish
Pages2919-2920
Number of pages2
Volume42
Issue number10
JournalClinical rheumatology
Publication statusPublished - Oct 2023
Peer-reviewedYes
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical

External IDs

PubMedCentral PMC10497701
Scopus 85163983996

Keywords